Inhibiting mTOR signaling down-regulates PKM2 expression and suppresses cancer metabolism, as demonstrated by decreased glucose uptake, lactate production (aerobic glycolysis), and reduced anabolism (macromolecule synthesis) in various cancer cell lines [18,19]. The gene discussed is PKM; the disease is cancer.